SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CHINA BIOLOGIC PRODUCTS
(NQNM:CBPO Last Sale: 105 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (CBPO : $105)
$4,132,970 million Market Cap at Market Close, July 1, 2022
Employs 1,324.
Drugs SubIndustry up .00% / Health Industry up .00% Today
No 14 East Hushan Road Research Report Earnings Snapshot - Last 11/05/18
Taian City, Fact Sheet
China Financial Statements
Phone: 86 53 8620 2306 Peer Comparison
Annual Reports

Ming Zhao Chao, CEO/Pres., Yu-Yun Tristan Kuo, CFO
Maker of plasma-based pharmaceutical products in the People's Republic of China. Offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; prevention and cure of low-density-lipoproteinemia; and Neonatal hyperbilirubinemia. Also provides Human Hepatitis B Immunoglobulin for the prevention of measles and contagious hepatitis; Human Immunoglobulin and Human Immunoglobulin for Intravenous Injection for original immunoglobulin deficiency, secondary immunoglobulin deficiency, and auto-immune deficiency diseases; and Thymopolypeptides Injection as a cure for various original and secondary T-cell deficiency syndromes, auto-immune deficiency diseases, and various cell immunity deficiency diseases, as well as assists in the treatment for tumors.
Historical Charts    Technical Analysis
No Historical Data available for CBPO

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CBPO $105 $105 0 .0 $104.71 $107.03 42,809 $104.71 $107.03 39,361,616
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex